# Pipeline Activity Log

> **Review:** Adjuvant progestagens for endometrial cancer  
> **Date:** 2026-05-21 23:06  
> **Duration:** 18m 57s  
> **Total tokens:** 197,412 (input: 111,024 / output: 86,388)

> **Review URL:** https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001040.pub2/full  
> **Dataset split:** dev  
> **Studies:** 10  
> **Model Profile:** openrouter_gpt5  
> **Orchestrator Model:** openai | openai/gpt-5  
> **Orchestrator API Base:** https://openrouter.ai/api/v1  
> **Orchestrator Request Config:** {"extra_body": {"provider": {"allow_fallbacks": false, "order": ["openai/default"], "require_parameters": true}, "reasoning": {"effort": "xhigh"}}}  
> **Librarian Model:** openai | openai/gpt-5  
> **Librarian API Base:** https://openrouter.ai/api/v1  
> **Librarian Request Config:** {"extra_body": {"provider": {"allow_fallbacks": false, "order": ["openai/default"], "require_parameters": true}, "reasoning": {"effort": "xhigh"}}}  
> **Gatekeeper Model:** openai | openai/gpt-5  
> **Gatekeeper API Base:** https://openrouter.ai/api/v1  
> **Gatekeeper Request Config:** {"extra_body": {"provider": {"allow_fallbacks": false, "order": ["openai/default"], "require_parameters": true}, "reasoning": {"effort": "xhigh"}}}  
> **Miner Model:** openai | openai/gpt-5  
> **Miner API Base:** https://openrouter.ai/api/v1  
> **Miner Request Config:** {"extra_body": {"provider": {"allow_fallbacks": false, "order": ["openai/default"], "require_parameters": true}, "reasoning": {"effort": "xhigh"}}}  
> **Critic Model:** openai | openai/gpt-5  
> **Critic API Base:** https://openrouter.ai/api/v1  
> **Critic Request Config:** {"extra_body": {"provider": {"allow_fallbacks": false, "order": ["openai/default"], "require_parameters": true}, "reasoning": {"effort": "xhigh"}}}  

## Resource Usage by Agent

| Agent | Steps | Time | Tokens (in / out) |
|-------|-------|------|-------------------|
| Orchestrator | 7 | 18m 57s | 44,518 / 17,293 |
| Librarian | 3 | 1m 49s | 11,936 / 7,692 |
| Gatekeeper | 2 | 2m 41s | 12,025 / 14,776 |
| Miner | 2 | 3m 23s | 9,554 / 16,555 |
| Critic | 4 | 6m 50s | 32,991 / 30,072 |
| **Total** | **18** | **18m 57s** | **111,024 / 86,388** |

---

## Activity Timeline

### 1. Planning (Orchestrator)

*23:07:32 — 56s — 5,337 tokens*

The orchestrator reviewed the review question and defined the target evidence: randomized controlled trials of adjuvant progestagen therapy after surgery for endometrial cancer. It mapped out the end-to-end workflow, assigning specialized agents to search for studies, screen against eligibility, and extract key details on study design, population, interventions/comparators, outcomes (recurrence-free and overall survival, recurrence rates, adverse events), and follow-up. It also specified how to synthesize findings and assess quality (risk of bias, effect estimates or narrative synthesis, safety, heterogeneity, certainty) and to produce a final report and structured dataset. Outcome: a clear, executable plan with data requirements and responsibilities defined for the next steps.

---

### 2. Orchestrator → Librarian

*23:09:48 — 2m 16s — 27,135 tokens*

The orchestrator initiated the search phase by defining the review protocol for randomized trials of postoperative progestagen therapy in endometrial cancer and directing the librarian to run a comprehensive, language-inclusive search without pre-screening. After the search, it retrieved the list of all candidate studies for initial screening. Outcome: 10 candidate studies were identified.

> **Librarian — Step 1:** The librarian agent retrieved and reviewed the review protocol to confirm the background, objective, and eligibility criteria (randomized trials of adjuvant progestagens after surgery for endometrial cancer). This was done to guide construction of a comprehensive search strategy. In this step, only the protocol was obtained; no database search was executed and no candidate studies were retrieved yet.
> **Librarian — Step 2:** The librarian aimed to identify randomized trials of adjuvant progestagen therapy after surgery for endometrial cancer, per the review protocol. They built a comprehensive Boolean search combining condition, postoperative/adjuvant context, progestagen drug terms, and RCT indicators, and ran it in the literature database, checking the raw output format. The search retrieved 10 candidate studies with titles and abstracts for further screening.
> **Librarian — Step 3 (result):** The librarian agent parsed the raw search output and converted it into a structured list of studies with titles and abstracts. It documented the exact search strategy and Boolean query (covering endometrial cancer, adjuvant context, progestagen agents, and randomized-trial terms) with no date or language limits. The final output contained 10 candidate studies on adjuvant progestagen therapy after surgery for endometrial cancer, ready for screening.

---

### 3. Orchestrator → Gatekeeper

*23:13:04 — 3m 15s — 36,452 tokens*

The orchestrator initiated the screening phase by directing a screening agent to evaluate each candidate study against the predefined criterion: randomized controlled trials of postoperative progestagen therapy in women after surgery for endometrial cancer, with brief justifications for each decision. It then compiled the studies marked as included and tallied them. Outcome: 4 studies met the criteria and were included.

> **Gatekeeper — Step 1:** The gatekeeper aimed to screen each study for inclusion as randomized trials of postoperative progestagen therapy for endometrial cancer, planning to include only clearly eligible trials and flag uncertainties. It retrieved the batch of 10 candidate studies, confirmed the selection criteria, and displayed study details to begin assessment, reviewing the first abstract. No inclusion/exclusion decisions were finalized at this step.
> **Gatekeeper — Step 2 (result):** The agent screened 10 candidate studies to find randomized controlled trials of postoperative (adjuvant) progestagen therapy in women treated surgically for endometrial cancer. It included four trials that randomized patients after surgery to progestagens versus control, and excluded six records that were reviews, methodological papers, or not clearly postoperative RCTs. Each decision included a brief rationale and a confidence rating, with uncertainty noted for borderline cases.

---

### 4. Orchestrator → Miner

*23:16:54 — 3m 50s — 35,759 tokens*

The orchestrator advanced to the extraction stage and directed a specialized miner to pull structured evidence from the included randomized controlled trials, aligned with the review objective. It requested study identifiers, population details, progestagen regimens and comparators, outcomes (recurrence, survival, adverse events), effect measures with follow-up, and any notes on risk of bias or funding. The extraction task was executed and marked complete, and the miner’s output was captured for use in subsequent synthesis steps.

> **Miner — Step 1:** The agent set out to extract structured PICO elements, outcomes, and key findings from all randomized trials on adjuvant progestagen therapy for endometrial cancer. It processed four study abstracts and generated structured summaries aligned to the review question. The extracted findings included that in a large multicentre trial, adding medroxyprogesterone acetate did not significantly improve relapse-free survival or cure rates over long-term follow-up, with details from the other trial(s) captured as available for synthesis.
> **Miner — Step 2 (result):** The miner finalized structured evidence extraction from the included RCTs by creating standardized PICO summaries per study, capturing population, setting, interventions, comparators, outcomes, design, follow-up, adverse events, and key findings. It recorded available p-values and event counts and marked effect estimates and confidence intervals as not reported when absent, with clarifying notes. The resulting study-level evidence set indicates, for example, that adjuvant medroxyprogesterone acetate did not improve relapse-free survival at 84 months in postoperative Stage I endometrial cancer.

---

### 5. Planning (Orchestrator)

*23:17:19 — 26s — 5,580 tokens*

The orchestrator reviewed the protocol for evaluating adjuvant progestagens in endometrial cancer and assessed pipeline progress. It confirmed that the search yielded 10 candidate studies, screening included 4 randomized trials, and data extraction was completed. It then set the next steps: synthesize the evidence from the included trials, generate a clear report, save the structured evidence, and return the final report.

---

### 6. Orchestrator → Critic

*23:24:36 — 7m 16s — 74,361 tokens*

The orchestrator initiated the synthesis phase, directing a quality-assessment agent to evaluate risk of bias and synthesize the extracted evidence from randomized trials of adjuvant progestagen therapy after endometrial cancer surgery. It requested a narrative summary of effectiveness and safety, discussion of effect directions and precision, heterogeneity, applicability, overall certainty, practice implications, and research gaps. The synthesis task completed successfully, and the resulting assessment and narrative synthesis were saved for the review.

> **Critic — Step 1:** The agent aimed to organize the mined studies, appraise their quality, and prepare a synthesis. It extracted and organized the evidence, confirming four studies on adjuvant progestagen therapy versus observation or placebo after surgery for early-stage endometrial cancer, and summarized each study’s population, intervention, and comparator. This established a clean dataset for the subsequent risk-of-bias assessment and narrative synthesis.
> **Critic — Step 2:** The critic aimed to prepare the included studies for risk-of-bias assessment and evidence synthesis. It submitted the previously extracted study data to a quality-assessment step, which organized key details such as design, interventions, comparators, outcomes, follow-up, and findings. The process completed without errors and produced a structured summary ready for subsequent bias judgments and narrative synthesis.
> **Critic — Step 3:** The critic began the synthesis by creating a traceable record linked to the review question on the effectiveness and safety of adjuvant progestagen therapy in endometrial cancer. It processed the extracted evidence and generated a structured summary of an included randomized trial in Stage I disease comparing medroxyprogesterone acetate with observation/radiotherapy. The output showed no significant improvement in relapse-free survival or cure rate with medroxyprogesterone and noted that adverse events were not reported, laying the groundwork for subsequent risk-of-bias assessment and narrative synthesis.
> **Critic — Step 4 (result):** The critic synthesized the miner’s extracted randomized trials on adjuvant progestagens after surgery for early-stage endometrial cancer and conducted study-level quality and applicability assessments. It produced a citation-backed narrative of benefits and harms, highlighting unclear methods, heterogeneity in regimens and co-interventions, and sparse adverse event reporting. The synthesis found no consistent reduction in recurrence or survival, a possible OS benefit in one small, high-bias study, and a signal for higher non-cancer mortality in a large trial. It concluded that routine adjuvant progestagen therapy is not supported, with overall evidence strength rated moderate.

---

### 7. Final Output (Orchestrator)

*23:25:34 — 58s — 12,788 tokens*

To finalize the review, the orchestrator prepared the final report for the systematic review of adjuvant progestagens for endometrial cancer. It consolidated the objective, search yield (10 candidates), screening outcomes (4 included, 6 excluded), and the extracted evidence and synthesis, and saved the corresponding structured data for record‑keeping. The completed report was delivered to the user and the data were successfully archived.

---
